Net Cash Provided by (Used in) Operating Activities of AVAI BIO, INC. from 30 Jun 2018 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary
AVAI BIO, INC. quarterly and annual Net Cash Provided by (Used in) Operating Activities in USD history and change rate from 30 Jun 2018 to 30 Jun 2025.
  • AVAI BIO, INC. Net Cash Provided by (Used in) Operating Activities for the quarter ending 30 Jun 2025 was $240,343, a 1792% decline year-over-year.
  • AVAI BIO, INC. annual Net Cash Provided by (Used in) Operating Activities for 2024 was $1,160,610, a 12% increase from 2023.
  • AVAI BIO, INC. annual Net Cash Provided by (Used in) Operating Activities for 2023 was $1,322,318, a 2328% decline from 2022.
  • AVAI BIO, INC. annual Net Cash Provided by (Used in) Operating Activities for 2022 was $54,457, a 110% decline from 2021.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Change (%)

AVAI BIO, INC. Quarterly Net Cash Provided by (Used in) Operating Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $240,343 -$227,641 -1792% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025 2026 Q1
Q2 2024 $12,702 +$47,024 +79% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025 2026 Q1
Q2 2023 $59,726 +$35,870 +38% 01 Apr 2023 30 Jun 2023 10-Q/A 21 Jan 2025 2025 Q1
Q2 2022 $95,596 -$152,536 -268% 01 Apr 2022 30 Jun 2022 10-Q 16 Aug 2023 2023 Q1
Q2 2021 $56,940 +$80,941 01 Apr 2021 30 Jun 2021 10-Q 19 Aug 2022 2023 Q1
Q2 2020 $24,001 -$18,118 -308% 01 Apr 2020 30 Jun 2020 10-Q 23 Aug 2021 2021 Q1
Q2 2019 $5,883 -$287 -5.1% 01 Apr 2019 30 Jun 2019 10-Q/A 17 Oct 2019 2020 Q1
Q2 2018 $5,596 01 Apr 2018 30 Jun 2018 10-Q/A 17 Oct 2019 2020 Q1

AVAI BIO, INC. Annual Net Cash Provided by (Used in) Operating Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $1,160,610 +$161,708 +12% 01 Apr 2024 31 Mar 2025 10-K 08 Jul 2025 2025 FY
2023 $1,322,318 -$1,267,861 -2328% 01 Apr 2023 31 Mar 2024 10-K 08 Jul 2025 2025 FY
2022 $54,457 -$589,465 -110% 01 Apr 2022 31 Mar 2023 10-K/A 19 Feb 2025 2024 FY
2021 $535,008 +$511,918 +2217% 01 Apr 2021 31 Mar 2022 10-K/A 13 Jul 2023 2022 FY
2020 $23,090 -$107,628 -82% 01 Apr 2020 31 Mar 2021 10-K 29 Jun 2022 2022 FY
2019 $130,718 +$214,883 05 Apr 2019 31 Mar 2020 10-K/A 18 Aug 2021 2021 FY
2018 $84,165 01 Apr 2018 31 Mar 2019 10-K 15 Jul 2019 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.